510(k) K243753

cobas liat Bordetella panel nucleic acid test by Roche Molecular Systems, Inc. — Product Code OZZ

K243753 is an FDA 510(k) premarket notification submitted by Roche Molecular Systems, Inc. for the device "cobas liat Bordetella panel nucleic acid test". The FDA issued a decision of Substantially Equivalent on Nov 20, 2025. The device falls under product code OZZ (Bordetella Pertussis Dna Assay System), a Class II device regulated under 21 CFR 866.3980. Roche Molecular Systems, Inc. has 54 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Nov 20, 2025
Date Received
Dec 5, 2024
Clearance Type
Dual Track
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Bordetella Pertussis Dna Assay System
Device Class
Class II
Regulation Number
866.3980
Review Panel
MI
Submission Type
510(k)

A qualitative in vitro diagnostic assay intended to detect Bordetella pertussis DNA extracted from human respiratory specimens. Detection of Bordetella pertussis DNA aids in the diagnosis of Bordetella pertussis respiratory infection in conjunction with other clinical and laboratory testing in patients exhibiting signs and symptoms of upper respiratory tract infection.

Need the full FDA record for Roche Molecular Systems, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K243753. Report a data issue: hello@regdatalab.com.